Hi, I am a scientist, founder and investor.
I work and invest in startups that move atoms and bits. Recent investments include Culdesac, Vial, Benchling, Neuralink, and Freenome. Byers Capital leads and participates in financings, most often Series A and B rounds.
I cofounded NewLimit with Brian Armstrong to extend human health span by inventing epigenetic reprogramming medicines. We are actively recruiting for scientific team members, come join us!
I was a partner at Google Ventures for a decade where we scaled the firm from a $50M fund to a $2.5B fund. My early stage investments at GV included Robinhood (Nasdaq: HOOD), IonQ (Nasdaq: IONQ), Denali (Nasdaq: DNLI), Arcus (Nasdaq: RCUS), Grail (acquired by Illumina), Dapper, Blockchain.com, and Gusto.
I used to conduct basic research in stem cell biology and optogenetics.